期刊文献+

甲状腺功能减退与房颤发生风险关系的Meta分析 被引量:4

Hypothyroidism and risk of atrial fibrillation: a meta-analysis
原文传递
导出
摘要 目的系统评价甲状腺功能减退与房颤发生风险的关系。方法计算机检索PubMed、EMbase、The Cochrane Library、Web of Science、CNKI、CBM、VIP和WanFang Data数据库,搜集国内外发表的甲状腺功能减退与房颤发生关系的队列研究和病例-对照研究,检索时限均为建库至2019年11月。由2名研究者独立筛选文献、提取资料并评价纳入研究的偏倚风险后,采用RevMan 5.3软件进行Meta分析。结果共纳入5个队列研究,包括574 268例患者,累计发生房颤18 059例。Meta分析结果显示:与甲状腺功能正常人群相比,甲状腺功能减退人群不会增加房颤的发生风险[OR=1.10,95%CI(0.75,1.61),P=0.62];亚组Meta分析结果显示:与甲状腺功能正常人群相比,甲状腺功能减退不会增加社区人群[OR=0.97,95%CI(0.72,1.29),P=0.82]及心脏术后患者[OR=1.22,95%CI(0.58,2.53),P=0.60]的房颤发生风险。结论当前证据显示,甲状腺功能减退不会增加房颤的发生风险。受纳入研究数量和质量限制,上述结论尚待更多高质量研究予以验证。 Objectives To systematically review the relationship between hypothyroidism and the risk of atrial fibrillation. Method PubMed, EMbase, The Cochrane Library, Web of Science, CNKI, CBM, VIP and WanFang Data databases were electronically searched to collect cohort and case-control studies on the association between hypothyroidism and atrial fibrillation from inception to November 2019. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Meta-analysis was then performed using RevMan 5.3 software. Results A total of 5 cohort studies involving 574 268 subjects and 18 059 atrial fibrillation cases were included.The results of meta-analysis showed that hypothyroidism was not associated with atrial fibrillation(OR=1.10, 95%CI 0.75 to 1.61, P=0.62). From subgroup analysis, no relationship was identified in community population(OR=0.97, 95%CI 0.72 to 1.29, P=0.82) and cardiac surgery patients(OR=1.22, 95%CI 0.58 to 2.53, P=0.60). Conclusions Hypothyroidism does not increase the risk of atrial fibrillation. Due to limited quality and quantity of the included studies, more high-quality studies are required to verify the above conclusions.
作者 向玉萍 曾玲 罗天会 赵琴 钱永军 XIANG Yuping;ZENG Ling;LUO Tianhui;ZHAO Qin;QIAN Yongjun(Department of Intensive Care Unit,West China Hospital,Sichuan University,Chengdu 610041,P.R.China;Department of Cardiovascular Surgery,National Clinical Research Center for Geriatrics,West China Hospital,Sichuan University,Chengdu 610041,P.R.China)
出处 《中国循证医学杂志》 CSCD 北大核心 2020年第5期556-561,共6页 Chinese Journal of Evidence-based Medicine
基金 国家重点研发专项项目(编号:2016YFC1302003) 四川省科技计划重点研发计划项目(编号:2017SZ0056) 国家老年疾病临床医学研究中心(四川大学华西医院)立项资助课题(编号:Z2018B19) 四川省干部保健科研课题(编号:川干研2019-101)。
关键词 甲状腺功能减退 房颤 META分析 系统评价 队列研究 病例-对照研究 Hypothyroidism Atrial fibrillation Meta-analysis Systematic review Cohort study Case-control study
  • 相关文献

参考文献1

二级参考文献15

  • 1无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2072
  • 2Karras S,Tzotzas T,Kaltsas T,et al. Pharmacologicaltreatment of hyperthyroidism during lactation : review ofthe literature and novel data [ J ] ? Pediatr EndocrinolRev,2010,8(l) :25 -33.
  • 3Ghandour A,Reust C. Hyperthyroidism: a stepwise ap-proach to management [ J]. J Fain Pract,2011,60(7):388 -395.
  • 4Mansourian AR. A review of literature on the adverseeffects of hyperthyroidism on the heart functional behav-ior [J]. Pak J Biol Sci,2012,15(4) : 164-176.
  • 5Rakhmatullov FK, Klimova SV, Rudakova LE, et al.The influence of subclinical thyroid dysfunction on car-diac hemodynamie and eleclmphysiological parametersin patients with coronary heart disease and paroxysmalatrial fibrillation [J]. Klin Med ( Mosk ),2012,90(3):31 -34.
  • 6Lip GY, Halperin JL, Tse HF. The 2010 European So-ciety of Cardiology Guidelines on the management of at-rial fibrillation : an evolution or revolution [ J ] . Chest,2011,139(8) :738 -741.
  • 7Auer J, Scheibner P, Mische T, et al. Subclinical hy-perthyroidism as a risk factor for atrial fibrillation [ J].Am Heart J, 2001,142(9) :838 -842.
  • 8Park YJ,Yoon JW, Kim KI, et al. Subclinical hypothy-roidism might increase the risk of transient atrial fibril-lation after coronary artery bypass grafting [ J]. AnnThorae Surg,2009,87( 13) :1B46-1852.
  • 9Biondi B, Palmieri EA, Lombardi G,et al. Effects ofsubclinical thyroid dysfunction on the heart [ J ], AnnIntern Med,2002,137( 10) :904 - 914.
  • 10Nyrues A,Njolstad I,Mathiesen EB,et al. Inflammatorybiomarkers as risk factors for future atrial fibrillation.An eleven - year follow - up of 6315 men and women :the Tromso study [ J]. Gend Med,2012,9(6) : 536 -547.

共引文献3

同被引文献41

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部